Leukemia Clinical Trials in Massachusetts

Showing 1001-1020 of 1,253 trials

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

NCT01606579

PRI-724 is a new investigational drug being studied to treat subjects with cancer who have advanced myeloid malignancies. PRI-724 is thought to work by blocking the Wnt signaling pathway that cancer cells need to grow and spread (metastasize).

Acute Myeloid LeukemiaChronic Myeloid Leukemia

Prism Pharma Co., Ltd.49 participantsStarted Jul 2012

Atlanta, Georgia, United States • Worcester, Massachusetts, United States • Albuquerque, New Mexico, United States +3 more locations

COMPLETED14 miles

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

NCT00437060

This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.

Childhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaCognitive Side Effects of Cancer Therapy+4 more

Children's Oncology Group233 participantsStarted Jan 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Downey, California, United States +109 more locations

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Leukemia Trials in Other Cities

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Pulsatile GnRH in Anovulatory Infertility

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Individual and Contextual Factors That Influence Sexual Decisions

Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Weaning And Variability Evaluation

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Other Conditions in Massachusetts